Payers’ experiences with confidential pharmaceutical price discounts: A survey of public and statutory health systems in North America, Europe, and Australasia

Highlights • Confidential discounts are now common and often significant among in many countries. • Discounts range widely but are most commonly over 20% of list prices. • Confidential price discounts were more common, complex, and significant for specialty pharmaceuticals. • Views of discounts refl...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Health policy (Amsterdam) 2017-04, Vol.121 (4), p.354-362
Hauptverfasser:	Morgan, Steven G, Vogler, Sabine, Wagner, Anita K
Format:	Artikel
Sprache:	eng
Schlagworte:	Attitudes Australasia Bargaining Confidentiality Costs and Cost Analysis - economics Coverage Discounting Discounts Drug Costs - statistics & numerical data Drug Industry - economics Drugs Europe Health administration Health care policy Humans Internal Medicine Negotiating North America Pharmaceuticals Polls & surveys Prescription drugs Prices Primary care Rebates Reimbursement Survey Surveys and Questionnaires
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Highlights • Confidential discounts are now common and often significant among in many countries. • Discounts range widely but are most commonly over 20% of list prices. • Confidential price discounts were more common, complex, and significant for specialty pharmaceuticals. • Views of discounts reflected tensions between local system goals and global impacts.
ISSN:	0168-8510 1872-6054
DOI:	10.1016/j.healthpol.2017.02.002